POT1 Tumor Predisposition

Sponsored diagnostic testing programs for POT1 Tumor Predisposition

POT1 Tumor Predisposition is an inherited cancer-risk syndrome caused by pathogenic variants in POT1, a key telomere-maintenance gene. Affected individuals have increased susceptibility to melanoma, glioma, chronic lymphocytic leukemia, and other tumors, often presenting at earlier ages.

1 program found for POT1 Tumor Predisposition

Programs

1 program
Invitae Unlock™

Invitae Inborn Errors of Immunity and Cytopenias Panel

Invitae Unlock Immunology offers sponsored access to the Inborn Errors of Immunity and Cytopenias Panel, Invitae’s most comprehensive assay for evaluating inherited immune disorders and cytopenias. The panel includes genes tied to combined immunodeficiencies, immune dysregulation, and bone marrow failure, supporting clearer diagnosis and management. U.S. providers may order for eligible patients.

Immunology
ViewOrder
Performing labInvitae | Labcorp